Burns Treatment - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509248143

Publication Date:

September 10, 2024

Pages:

124

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Burns Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Burns Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Burns Treatment by region & country, by Type, and by Application.
The Burns Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Burns Treatment.
麻豆原创 Segmentation
By Company
Adocia
AlgiPharma AS
Amarantus Bioscience Holdings, Inc.
American Gene Technologies International Inc.
Biogenomics Limited
CytoTools AG
Destiny Pharma Limited
Lakewood-Amedex Inc
Madam Therapeutics B.V.
MediWound Ltd.
Mitochon Pharmaceuticals, Inc.
Phosphagenics Limited
Se-cure Pharmaceuticals Ltd.
Sinclair Pharma Plc
Stratatech Corporation
Tissue Therapies Limited
USV Pvt Ltd
Segment by Type:
ENERGIF-711
AG-110
NJ-01SS
P-148
Others
Segment by Application
In-patient
Out-patient
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Burns Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Burns Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Burns Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Burns Treatment Product Introduction
1.2 Global Burns Treatment 麻豆原创 Size Forecast
1.3 Burns Treatment 麻豆原创 Trends & Drivers
1.3.1 Burns Treatment Industry Trends
1.3.2 Burns Treatment 麻豆原创 Drivers & Opportunity
1.3.3 Burns Treatment 麻豆原创 Challenges
1.3.4 Burns Treatment 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Burns Treatment Players Revenue Ranking (2023)
2.2 Global Burns Treatment Revenue by Company (2019-2024)
2.3 Key Companies Burns Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Burns Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Burns Treatment
2.6 Burns Treatment 麻豆原创 Competitive Analysis
2.6.1 Burns Treatment 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Burns Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burns Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ENERGIF-711
3.1.2 AG-110
3.1.3 NJ-01SS
3.1.4 P-148
3.1.5 Others
3.2 Global Burns Treatment Sales Value by Type
3.2.1 Global Burns Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Burns Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Burns Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 In-patient
4.1.2 Out-patient
4.2 Global Burns Treatment Sales Value by Application
4.2.1 Global Burns Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Burns Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Burns Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Burns Treatment Sales Value by Region
5.1.1 Global Burns Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Burns Treatment Sales Value by Region (2019-2024)
5.1.3 Global Burns Treatment Sales Value by Region (2025-2030)
5.1.4 Global Burns Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Burns Treatment Sales Value, 2019-2030
5.2.2 North America Burns Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Burns Treatment Sales Value, 2019-2030
5.3.2 Europe Burns Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Burns Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Burns Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Burns Treatment Sales Value, 2019-2030
5.5.2 South America Burns Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Burns Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Burns Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Burns Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Burns Treatment Sales Value
6.3 United States
6.3.1 United States Burns Treatment Sales Value, 2019-2030
6.3.2 United States Burns Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Burns Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Burns Treatment Sales Value, 2019-2030
6.4.2 Europe Burns Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Burns Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Burns Treatment Sales Value, 2019-2030
6.5.2 China Burns Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Burns Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Burns Treatment Sales Value, 2019-2030
6.6.2 Japan Burns Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Burns Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Burns Treatment Sales Value, 2019-2030
6.7.2 South Korea Burns Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Burns Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Burns Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Burns Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Burns Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Burns Treatment Sales Value, 2019-2030
6.9.2 India Burns Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Burns Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Adocia
7.1.1 Adocia Profile
7.1.2 Adocia Main Business
7.1.3 Adocia Burns Treatment Products, Services and Solutions
7.1.4 Adocia Burns Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Adocia Recent Developments
7.2 AlgiPharma AS
7.2.1 AlgiPharma AS Profile
7.2.2 AlgiPharma AS Main Business
7.2.3 AlgiPharma AS Burns Treatment Products, Services and Solutions
7.2.4 AlgiPharma AS Burns Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 AlgiPharma AS Recent Developments
7.3 Amarantus Bioscience Holdings, Inc.
7.3.1 Amarantus Bioscience Holdings, Inc. Profile
7.3.2 Amarantus Bioscience Holdings, Inc. Main Business
7.3.3 Amarantus Bioscience Holdings, Inc. Burns Treatment Products, Services and Solutions
7.3.4 Amarantus Bioscience Holdings, Inc. Burns Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 American Gene Technologies International Inc. Recent Developments
7.4 American Gene Technologies International Inc.
7.4.1 American Gene Technologies International Inc. Profile
7.4.2 American Gene Technologies International Inc. Main Business
7.4.3 American Gene Technologies International Inc. Burns Treatment Products, Services and Solutions
7.4.4 American Gene Technologies International Inc. Burns Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 American Gene Technologies International Inc. Recent Developments
7.5 Biogenomics Limited
7.5.1 Biogenomics Limited Profile
7.5.2 Biogenomics Limited Main Business
7.5.3 Biogenomics Limited Burns Treatment Products, Services and Solutions
7.5.4 Biogenomics Limited Burns Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Biogenomics Limited Recent Developments
7.6 CytoTools AG
7.6.1 CytoTools AG Profile
7.6.2 CytoTools AG Main Business
7.6.3 CytoTools AG Burns Treatment Products, Services and Solutions
7.6.4 CytoTools AG Burns Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 CytoTools AG Recent Developments
7.7 Destiny Pharma Limited
7.7.1 Destiny Pharma Limited Profile
7.7.2 Destiny Pharma Limited Main Business
7.7.3 Destiny Pharma Limited Burns Treatment Products, Services and Solutions
7.7.4 Destiny Pharma Limited Burns Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Destiny Pharma Limited Recent Developments
7.8 Lakewood-Amedex Inc
7.8.1 Lakewood-Amedex Inc Profile
7.8.2 Lakewood-Amedex Inc Main Business
7.8.3 Lakewood-Amedex Inc Burns Treatment Products, Services and Solutions
7.8.4 Lakewood-Amedex Inc Burns Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Lakewood-Amedex Inc Recent Developments
7.9 Madam Therapeutics B.V.
7.9.1 Madam Therapeutics B.V. Profile
7.9.2 Madam Therapeutics B.V. Main Business
7.9.3 Madam Therapeutics B.V. Burns Treatment Products, Services and Solutions
7.9.4 Madam Therapeutics B.V. Burns Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Madam Therapeutics B.V. Recent Developments
7.10 MediWound Ltd.
7.10.1 MediWound Ltd. Profile
7.10.2 MediWound Ltd. Main Business
7.10.3 MediWound Ltd. Burns Treatment Products, Services and Solutions
7.10.4 MediWound Ltd. Burns Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 MediWound Ltd. Recent Developments
7.11 Mitochon Pharmaceuticals, Inc.
7.11.1 Mitochon Pharmaceuticals, Inc. Profile
7.11.2 Mitochon Pharmaceuticals, Inc. Main Business
7.11.3 Mitochon Pharmaceuticals, Inc. Burns Treatment Products, Services and Solutions
7.11.4 Mitochon Pharmaceuticals, Inc. Burns Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Mitochon Pharmaceuticals, Inc. Recent Developments
7.12 Phosphagenics Limited
7.12.1 Phosphagenics Limited Profile
7.12.2 Phosphagenics Limited Main Business
7.12.3 Phosphagenics Limited Burns Treatment Products, Services and Solutions
7.12.4 Phosphagenics Limited Burns Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Phosphagenics Limited Recent Developments
7.13 Se-cure Pharmaceuticals Ltd.
7.13.1 Se-cure Pharmaceuticals Ltd. Profile
7.13.2 Se-cure Pharmaceuticals Ltd. Main Business
7.13.3 Se-cure Pharmaceuticals Ltd. Burns Treatment Products, Services and Solutions
7.13.4 Se-cure Pharmaceuticals Ltd. Burns Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 Se-cure Pharmaceuticals Ltd. Recent Developments
7.14 Sinclair Pharma Plc
7.14.1 Sinclair Pharma Plc Profile
7.14.2 Sinclair Pharma Plc Main Business
7.14.3 Sinclair Pharma Plc Burns Treatment Products, Services and Solutions
7.14.4 Sinclair Pharma Plc Burns Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Sinclair Pharma Plc Recent Developments
7.15 Stratatech Corporation
7.15.1 Stratatech Corporation Profile
7.15.2 Stratatech Corporation Main Business
7.15.3 Stratatech Corporation Burns Treatment Products, Services and Solutions
7.15.4 Stratatech Corporation Burns Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Stratatech Corporation Recent Developments
7.16 Tissue Therapies Limited
7.16.1 Tissue Therapies Limited Profile
7.16.2 Tissue Therapies Limited Main Business
7.16.3 Tissue Therapies Limited Burns Treatment Products, Services and Solutions
7.16.4 Tissue Therapies Limited Burns Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Tissue Therapies Limited Recent Developments
7.17 USV Pvt Ltd
7.17.1 USV Pvt Ltd Profile
7.17.2 USV Pvt Ltd Main Business
7.17.3 USV Pvt Ltd Burns Treatment Products, Services and Solutions
7.17.4 USV Pvt Ltd Burns Treatment Revenue (US$ Million) & (2019-2024)
7.17.5 USV Pvt Ltd Recent Developments
8 Industry Chain Analysis
8.1 Burns Treatment Industrial Chain
8.2 Burns Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Burns Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Burns Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Adocia
AlgiPharma AS
Amarantus Bioscience Holdings, Inc.
American Gene Technologies International Inc.
Biogenomics Limited
CytoTools AG
Destiny Pharma Limited
Lakewood-Amedex Inc
Madam Therapeutics B.V.
MediWound Ltd.
Mitochon Pharmaceuticals, Inc.
Phosphagenics Limited
Se-cure Pharmaceuticals Ltd.
Sinclair Pharma Plc
Stratatech Corporation
Tissue Therapies Limited
USV Pvt Ltd

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.